Robert Reyes

A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia

Harold Bays, Leiv Ose, Neil J. Fraser et al. · Clinical Therapeutics · 2004 · 176 citations

Metabolic Syndrome, Thrombosis, Primary Hypercholesterolemia +12

Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.

John F. Paolini, Yale Mitchel, Robert Reyes et al. · The American Journal of Cardiology · 2007 · 161 citations

Lipid Disorder, Study Investigators, Cardiovascular Disease +7

The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study

Frank L. Lanza, Bruce Sahba, Howard J. Schwartz et al. · The American Journal of Gastroenterology · 2002 · 65 citations

Effects of Alendronate on Gastric and Duodenal Mucosa

Frank L. Lanza, M F Rack, Thomas Simon et al. · The American Journal of Gastroenterology · 1998 · 62 citations

Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: An exploratory analysis of archived samples using two commercially available techniques

Leiv Ose, Robert Reyes, Amy O. Johnson‐Levonas et al. · Clinical Therapeutics · 2007 · 30 citations

Metabolic Syndrome, Thrombosis, Primary Hypercholesterolemia +10